Stein M B
Department of Psychiatry (0985), University of California, San Diego, La Jolla 92093, USA.
Depress Anxiety. 1998;7(3):134-8. doi: 10.1002/(sici)1520-6394(1998)7:3<134::aid-da7>3.0.co;2-b.
In this Research Review, several recent clinical trials in panic disorder and social phobia are reviewed. First, two social phobia studies which used the monoamine oxidase type A inhibitors brofaromine and moclobemide are considered. Then, three panic disorder studies which used clonazepam, clomipramine or paroxetine, and citalopram are examined. These studies serve to strengthen the empirical research base regarding which treatments are useful in these disorders.
在本研究综述中，回顾了近期关于惊恐障碍和社交恐惧症的几项临床试验。首先，考虑了两项使用单胺氧化酶A抑制剂溴法罗明和吗氯贝胺的社交恐惧症研究。然后，考察了三项分别使用氯硝西泮、氯米帕明或帕罗西汀以及西酞普兰的惊恐障碍研究。这些研究有助于加强关于哪些治疗方法对这些疾病有效的实证研究基础。
